azigel
phytolab industria farmaceutica eireli - epp - hidroxido de alumÍnio, hidrÓxido de alumÍnio - antiacido
tasigna
novartis biociencias s.a - nilotinibe - antineoplasico
adempas
bayer ag - riociguat - hipertensão, pulmonar - anti-hipertensivos para hipertensão arterial pulmonar - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. a eficácia tem sido mostrado em uma pah de população, incluindo aetiologies de idiopática ou hereditários hap ou pah associada a doença do tecido conjuntivo. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.
kolantyl
sanofi medley farmacÊutica ltda. - antiacido
gelusil
uniÃo quÍmica farmacÊutica nacional s/a - antiacidos e antiulcerosos associados
gastrobion
kley hertz farmaceutica s.a - antiacidos e antiulcerosos associados
maalox
sanofi-aventis farmacÊutica ltda - antiacido
mylanta plus
johnson & johnson industrial ltda. - antiacido
sprycel
bristol-myers squibb farmacÊutica ltda - dasatinibe - antineoplasico
onglyza
bristol-myers squibb farmacÊutica ltda - antidiabeticos